Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 6, 2008, Pages

  Bratz, Ian N ^a   Dick, Gregory M ^a   Tune, Johnathan D ^a   Edwards, Jason M ^a   Neeb, Zachary P ^a   Dincer, U Deniz ^a   Sturek, Michael ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Nitric oxide; Ossabaw miniature swine; Potassium channels; Transient receptor potential vanilloid 1

Indexed keywords

CAPSAICIN; CAPSAZEPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKING AGENT; VANILLOID RECEPTOR 1; CALCIUM; DRUG DERIVATIVE; ENZYME INHIBITOR; MANGANESE; POTASSIUM CHANNEL; TRPV1 RECEPTOR; VANILLOID RECEPTOR; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; IMMUNOREACTIVITY; METABOLIC SYNDROME X; MINIPIG; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CORONARY BLOOD VESSEL; DISEASE MODEL; DOSE RESPONSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; MALE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; SWINE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; CALCIUM; CAPSAICIN; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MALE; MANGANESE; METABOLIC SYNDROME X; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OBESITY; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; SWINE; SWINE, MINIATURE; TRPV CATION CHANNELS; VASODILATION; VASODILATOR AGENTS;

EID: 49249086205     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01191.2007     Document Type: Article

References (56)

1. Amberg GC, Rossow CF, Navedo MF, Santana LF. NFATc3 regulates Kv2.1 expression in arterial smooth muscle. J Biol Chem 279: 47326-47334, 2004.
2. Balzer M, Lintschinger B, Groschner K. Evidence for a role of Trp proteins in the oxidative stress-induced membrane conductances of porcine aortic endothelial cells. Cardiovasc Res 42: 543-549, 1999.
3. Bohlen HG. Protein kinase βII in Zucker obese rats compromises oxygen and flow-mediated regulation of nitric oxide formation. Am J Physiol Heart Circ Physiol 286: H492-H497, 2004.
4. Breyne J, Vanheel B. Methanandamide hyperpolarizes gastric arteries by stimulation of TRPV1 receptors on perivascular CGRP containing nerves. J Cardiovasc Pharmacol 47: 303-309, 2006.
5. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 24: 487-517, 2001.
6. Dincer UD, Araiza A, Knudson JD, Shao CH, Bidasee KR, Tune JD. Dysfunction of cardiac ryanodine receptors in the metabolic syndrome. J Mol Cell Cardiol 41: 108-114, 2006.
7. Dincer UD, Araiza AG, Knudson JD, Molina PE, Tune JD. Sensitization of coronary alpha-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome. Microcirculation 13: 587-595, 2006.
8. Domenicali M, Ros J, Fernandez-Varo G, Cejudo-Martin P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, Rodes J, Jimenez W. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut 54: 522-527, 2005.
9. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56: 35-45, 2006.
10. 2+ signaling complex with ryanodine receptors and BKCa channels. Circ Res 97: 1270-1279, 2005.
11. Fiorio PA, Munaron L. Calcium influx, arachidonic acid,and control of endothelial cell proliferation. Cell Calcium 30: 235-244, 2001.
12. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27: 2444-2449, 2004.
13. Fujimoto S, Mori M, Tsushima H, Kunimatsu M. Capsaicin-induced, capsazepine-insensitive relaxation of the guinea-pig ileum. Eur J Pharmacol 530: 144-151, 2006.
14. Galili O, Versari D, Sattler KJ, Olson ML, Mannheim D, McConnell JP, Chade AR, Lerman LO, Lerman A. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 292: H904-H911, 2007.
15. 2+ elevation beneath the cell membrane. J Physiol 506: 109-125, 1998.
16. 2+ entry in human and bovine endothelial cells. J Physiol 482: 259-274, 1995.
17. Groschner K, Hingel S, Lintschinger B, Balzer M, Romanin C, Zhu X, Schreibmayer W. Trp proteins form store-operated cation channels in human vascular endothelial cells. FEBS Lett 437: 101-106, 1998.
18. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105: 2696-2698, 2002.
19. Grundy SM. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 8, Suppl 1: S21-S27, 2006.
20. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92: 399-404, 2007.
21. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164: 1066-1076, 2004.
22. Iannuzzi A, De MM, Bond MG, Sacchetti L, Fortunato G, Salvatore F, Mattiello A, Panico S, Rubba P. Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study). Am J Cardiol 96: 1162-1165, 2005.
23. 2+-permeable cation channel. Circ Res 88: 325-332, 2001.
24. Knudson JD, Dincer UD, Bratz IN, Sturek M, Dick GM, Tune JD. Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation 14: 317-338, 2007.
25. Kohler R, Heyken WT, Heinau P, Schubert R, Si H, Kacik M, Busch C, Grgic I, Maier T, Hoyer J. Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Arterioscler Thromb Vasc Biol 26: 1495-1502, 2006.
26. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002.
27. Liu D, Scholze A, Zhu Z, Krueger K, Thilo F, Burkert A, Streffer K, Holz S, Harteneck C, Zidek W, Tepel M. Transient receptor potential channels in essential hypertension. J Hypertens 24: 1105-1114, 2006.
28. + current in arterial smooth muscle cells from aldosterone-salt hypertensive rats. Am J Physiol Heart Circ Physiol 269: H1246-H1257, 1995.
29. Lizanecz E, Bagi Z, Pasztor ET, Papp Z, Edes I, Kedei N, Blumberg PM, Toth A. Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. Mol Pharmacol 69: 1015-1023, 2006.
30. 2 and TRPV4 channels regulate endothelial calcium in cerebral arteries. Am J Physiol Heart Circ Physiol 292: H1390-H1397, 2007.
31. Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin 22: 485-504, 2004.
32. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A. Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 279: 25665-25672, 2004.
33. Nilius B. TRP channels in disease. Biochim Biophys Acta 1772: 805-812, 2007.
34. Nilius B, Droogmans G, Wondergem R. Transient receptor potential channels in endothelium: solving the calcium entry puzzle? Endothelium 10: 5-15, 2003.
35. Otis CR, Wamhoff BR, Sturek M. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp Med 53: 53-64, 2003.
36. Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J Physiol 568: 539-551, 2005.
37. Scotland RS, Chauhan S, Davis C, De FC, Hunt S, Kabir J, Kotsonis P, Oh U, Ahluwalia A. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res 95: 1027-1034, 2004.
38. + channel by Nedd4 and ubiquitination. Kidney Int 57: 809-815, 2000.
39. + channel (ENaC). Am J Physiol Cell Physiol 272: C1871-C1880, 1997.
40. Stepp DW, Pollock DM, Frisbee JC. Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 286: H964-H970, 2004.
41. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212, 1999.
42. + channel blocker aprindine. Biochem Biophys Res Commun 331: 1001-1006, 2005.
43. 2+ signaling, TRP channels, and endothelial permeability. Microcirculation 13: 693-708, 2006.
44. 2+ in smooth muscle cells from bovine and porcine coronary artery: modulation of sarcoplasmic reticulum function. Br J Pharmacol 105: 903-911, 1992.
45. Wang Y, Wang DH. A novel mechanism contributing to development of Dahl salt-sensitive hypertension: role of the transient receptor potential vanilloid type 1. Hypertension 47: 609-614, 2006.
46. Wegierski T, Hill K, Schaefer M, Walz G. The HECT ubiquitin ligase AIP4 regulates the cell surface expression of select TRP channels. EMBO J 25: 5659-5669, 2006.
47. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90: 248-250, 2002.
48. Witczak CA, Sturek M. Exercise prevents diabetes-induced impairment in superficial buffer barrier in porcine coronary smooth muscle. J Appl Physiol 96: 1069-1079, 2004.
49. 2+ channels in native vascular smooth muscle cells. Circ Res 88: 84-87, 2001.
50. Yan C, Lu D, Hai T, Boyd DD. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 24: 2425-2435, 2005.
51. Yang XR, Lin MJ, McIntosh LS, Sham JS. Functional expression of transient receptor potential melastatin- and vanilloid-related channels in pulmonary arterial and aortic smooth muscle. Am J Physiol Lung Cell Mol Physiol 290: L1267-L1276, 2006.
52. Yao X, Garland CJ. Recent developments in vascular endothelial cell transient receptor potential channels. Circ Res 97: 853-863, 2005.
53. Zahner MR, Li DP, Chen SR, Pan HL. Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol 551: 515-523, 2003.
54. Zanchi A, Delacretaz E, Taleb V, Gaillard R, Jeanrenaud B, Brunner HR, Waeber B. Endothelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia. J Hypertens 13: 1463-1470, 1995.
55. Zhang LL, Yan LD, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, Schrader M, Thilo F, Zhu ZM, Tepel M. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 100: 1063-1070, 2007.
56. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di M, V, Julius D, Hogestatt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457, 1999.